ClinicalThought

Share

Program Content

Activities

  • Targeting TIGIT: Commentary
    Targeting TIGIT: A Novel Mechanism to Inhibit the Immune Checkpoint Pathway
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 14, 2022

    Expires: April 13, 2023

  • Anti-TIGIT Therapy
    Anti-TIGIT Therapy: Current Evidence and Key Ongoing Trials
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 03, 2022

    Expires: May 02, 2023

Provided by

ProCE Banner

Supporters

Genentech, a member of the Roche Group